IRICoR is delighted to announce the appointment of Catherine Bouchard as Chair of its Audit and Finance Committee

 

Since 2017, Catherine Bouchard sits on IRICoR’s Board of Directors on which she brings more than 10 years of experience in healthcare equity research. She is currently Head of Research, Life Sciences at the Caisse de dépôt et placement du Québec, where she has served as Senior Healthcare Analyst since 2012. Prior to joining CDPQ, Ms. Bouchard spent five years at Valeurs Mobilières Banque Laurentienne, where she was the Lead Analyst covering healthcare stocks. Her expertise in industry analysis and her deep knowledge of the healthcare sector will be key additions for IRICoR. She holds a B.Sc. in Microbiology and Immunology and a M.Sc. in Biomedical Sciences from Université de Montréal, as well as an MBA from HEC Montreal.

 “We are delighted about Ms. Bouchard’s new appointment within our organization. Her critical expertise in the field of healthcare financing is already a precious asset at IRICoR’s Board and will be an added wealth for us with Ms. Bouchard as Chair of our Audit Committee”, pointed out Nadine Beauger, Chief Executive Officer, IRICoR.

Ms. Bouchard thus succeeds Mr. Jean-François Leprince. IRICoR would like to thank Mr. Leprince who, as IRICoR’s Chair of the Board, will remain a member of the Audit Committee.